INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780VAB8. A total of 10 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,108,000 | -70.8% | 1,000,000 | -73.3% | 0.08% | -70.9% |
| Q2 2018 | $3,796,000 | -20.7% | 3,750,000 | -25.0% | 0.26% | -29.9% |
| Q1 2018 | $4,785,000 | -31.8% | 5,000,000 | -42.9% | 0.38% | -16.4% |
| Q4 2017 | $7,016,000 | -7.3% | 8,750,000 | -9.8% | 0.45% | -8.3% |
| Q3 2017 | $7,572,000 | +30.9% | 9,700,000 | 0.0% | 0.49% | +24.8% |
| Q2 2017 | $5,784,000 | +1.1% | 9,700,000 | 0.0% | 0.40% | +25.8% |
| Q1 2017 | $5,723,000 | -3.5% | 9,700,000 | +70.2% | 0.31% | +9.4% |
| Q4 2016 | $5,928,000 | -22.7% | 5,700,000 | 0.0% | 0.29% | -18.5% |
| Q3 2016 | $7,670,000 | – | 5,700,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|